11 | BUDT 266% v2,15M c.110 f3,5M H.1103 | znewcar1 | 03/26/2020 4:01:47 PM |
10 | FLTT Financials 07/16/2014 10:10:21 Flint Telecom | Emylers | 07/16/2014 11:10:17 AM |
9 | FLTT 0.0003 Stock Charts $FLTT 1 Month Chart | chartguy89 | 03/07/2014 6:36:01 AM |
8 | FLTT Stock Charts Last: -0.0001 Wednesday, | chartguy89 | 02/26/2014 4:56:54 AM |
7 | $FLTT daily & weekly stock charts available | RobInvest | 10/20/2012 2:11:27 PM |
6 | FLTT gonna fly this week! Big time noise going on | MicroCapStocksRock | 09/16/2012 10:03:35 PM |
5 | It's constantly improving... | 11072017 | 09/14/2012 12:41:15 PM |
4 | This looks a little different over here, sense | Bronson | 09/14/2012 11:43:02 AM |
3 | FLTT +200% into a holiday weekend, looking good | Vikingzskillz | 09/03/2012 5:22:17 PM |
2 | Me thinks your right GoGetter, it's looking good. | 11072017 | 03/29/2012 1:33:37 PM |
1 | Me thinks this micropenny stock is getting ready | GoGetter | 03/29/2012 1:28:44 PM |
Recent Articles
- Opportunity for Wolfspeed Investors to Pursue Class Action
- Kyverna Therapeutics Investors Alert Over Recent Class Action
- Marqeta Inc. SEC Class Action Lawsuit: What Investors Need to Know
- Urgent Alert for Symbotic Investors Regarding Class Action
- Investors Reminded of Key Deadline in PACS Group Lawsuits
- Crucial Update for Five9 Investors: Lawsuit Deadline Approaching
- Important Update for Rentokil Investors on Class Action Lawsuit
- Important Update for Match Group Investors: Legal Actions Ahead
- Investors Urged to Act in Zeta Global Class Action Case
- Celsius Holdings Investors: Important Litigation Updates
- ASML Holding Class Action: Important Update for Investors
- Deadline Approaches for Hasbro Shareholders in Class Action
- Critical Update for Toronto-Dominion Bank Investors in Class Action
- Investors of Kyverna Therapeutics Can Pursue Class Action
- Xi Jinping Supports Hong Kong's Economic Strategies and Development
- Solar Alliance Energy Gains Shareholder Approval in Key Meeting
- Fruit Street Health Enhances Diabetes Prevention with Meals
- CNOOC Limited Partners with INEOS Energy in New Agreement
- Exciting Collaboration: Celebrate Japan's Fruit Culture
- Investors Urged to Act Before Deadline in Xiao-I Class Action
- Karma Sauce Applauds First We Feast's Bold New Direction
- Cassava Sciences Investors Encouraged to Act on Stock Losses
- Investors Warned of Upcoming Deadline in WM Technology Case
- Investors Urged to Act: Acadia Healthcare Class Action Deadline
- Aehr Test Systems Faces Class Action, Investors Urged to Act Soon
- Investors Alert: Upcoming Lead Plaintiff Motion Deadline for CUBI
- Legal Action Announced for Five9, Inc. Investors Following Stock Decline
- Legal Action Launched for Kyverna Therapeutics Investors
- Everlight Solar's Culture: A Testament to Team Camaraderie and Growth
- Haloid Enhances Safety in Film Productions with Reviews
- Insights on the Growing Demand for Edible Coatings in Produce
- Prospect Ridge Resources Adjusts Plans for Upcoming Meeting
- Legal Update: Toronto-Dominion Bank Securities Class Action
- Key Updates from Nasdaq on the Nasdaq-100 Index Changes
- TeraBox Revolutionizes File Sharing with Free Unlimited Service
- Kessler Topaz Takes Action Against Enphase Energy for Fraud
- Demesne Resources Completes Second Tranche of Financing
- Spiro Celebrated as One of the Top Agencies in Marketing
- Global Uranium Corp. Launches Strategic Marketing Efforts
- UnitedHealth Group Clarifies Misconceptions and Updates Claims
- Neurocrine Biosciences Unveils Potential of CRENESSITY™ for CAH
- Acadia Healthcare Investors Urged to Take Action on Lawsuit
- Global Uranium Corp. Unveils C$1.5 Million Flow-Through Offering
- Rakovina Therapeutics Secures $3M to Propel Cancer Therapy Advances
- Hola Prime's Innovative Vision: New Marketing Director Appointed
- Teamsters Advocate for Stronger Standards on Autonomous Vehicles
- BioVaxys Secures Funding and Enters Debt Settlement Agreement
- Exciting Advancement as UNLOXCYT Gains FDA Approval for Treatment
- OFS Credit Company Shares November Net Asset Value Insights
- New FDA Approval for Crenessity Enhances CAH Treatment Options